ComplianceOnline

Guidance for Industry - Adverse Reactions Section of Labeling for Human Prescription Drug and Biologic

  • Date: December 01, 2009
  • Source: www.fda.gov
Webinar All Access Pass Subscription Abstract:

This guidance represents the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call the appropriate number listed on the title page of this guidance

 

Bookmark and Share
Best Sellers
You Recently Viewed
    Loading